Skip to Main Content
  • Linde Worldwide
  • The Linde Group
  • About Linde
  • Careers
  • Glossary
  • Healthcare
    Hong Kong

  • Welcome to Linde Healthcare
  • About Linde Healthcare
      • Mission
      • Healthcare professionals
      • Patient-focused care
        • OXYTRAVEL®
      • Innovation
        • Innovation in healthcare
        • Your partner
        • REALfund
      • Key figures
      • Locations
  • Products and Services
      • Products and Services by category
        • Hospital equipment
          • Homecare devices, e.g., concentrators, masks
          • LIV
        • Medical gases
          • Calibration gases
          • Inhaled nitric oxide
          • Medical carbon dioxide
          • Medical helium/oxygen mixtures
          • Medicinal air
          • Medicinal nitrous oxide
          • Medicinal nitrous oxide/oxygen mixtures
          • Medicinal oxygen
        • QI Medical Gas Services
      • Products and Services by disease area
        • Anaesthesia
          • Medicinal air
          • Medicinal oxygen
          • Medicinal nitrous oxide
          • Medicinal nitrous oxide/oxygen mixtures
        • Intensive care
          • Medical helium/oxygen mixtures
          • Medicinal oxygen
        • Neonatology
          • Inhaled nitric oxide
        • Neurology
          • Medicinal oxygen for cluster headaches
        • Obstetrics
          • Medicinal nitrous oxide/oxygen mixtures
        • Pain
          • Medicinal nitrous oxide/oxygen mixtures
        • Pulmonology
          • Medicinal oxygen
      • Products and Services by care area
        • Emergency care
          • Linde Integrated Valve
          • Medicinal nitrous oxide/oxygen mixtures
          • Medicinal oxygen
          • Supplies and accessories
        • Homecare
          • Cluster headache
          • Linde Integrated Valve
          • Oxygen therapy
          • OXYTRAVEL
        • Hospital and clinical care
          • INOmax nitric oxide therapy
          • Linde Integrated Valve
          • Medicinal air
          • Medicinal nitrous oxide
          • Medicinal nitrous oxide/oxygen mixtures
          • Medicinal oxygen
  • Contact
  • News & Media
      • Press Releases
      • Events
        • Events Archive
      • Publications
      • Image Library
      • Media Contacts
  •  
  • Language
    • English
  • Linde Worldwide
  • The Linde Group
  • About Linde
  • Careers
  • Glossary
  • News & Media
  • Press Releases
  • Events
  • Publications
  • Image Library
  • Media Contacts
  • News & Media
  • Press Releases
  • 2009-04-06 The Linde Group and Sinopec subsidiary conclude long-term agreement on industrial gases supply in Chongqing, China

The Linde Group and Sinopec subsidiary conclude long-term agreement on industrial gases supply in Chongqing, China

Corporate News

Munich, 6 April 2009 - The technology group The Linde Group has secured a contract with Sinopec Sichuan Vinylon Works (SVW) to jointly build gas plants and produce industrial gases for the long-term supply to SVW's chemical complex. This collaboration will result in an initial investment of approximately EUR 50 million.

This partnership will establish a 50:50 joint venture between Linde Gas (Hong Kong) Limited and SVW in Chongqing Chemical Industrial Park (CCIP) by June 2009. SVW in Chongqing is mainly engaged in producing natural gas-based chemical and chemical fibre products, and is currently expanding its vinyl acetate monomer (VAM) production capabilities.

"We are looking forward to this promising partnership with SVW in Chongqing. This joint venture firmly casts Linde's geographical footprint in Western China," said Dr Aldo Belloni, member of the Executive Board of Linde AG. "Chongqing is a new territory for Linde, and our continued collaboration with Sinopec is a further example of our long-term growth strategy in China, underpinning our leading position in the Chinese gases market that continues to register a growth momentum in spite of the global economic downturn." 

"SVW is the only natural gas-based chemicals producer within Sinopec, and the largest gas-based chemical production site in China. Linde, in the same breath, is one of the largest industrial gas suppliers and engineering providers for customers in over 100 countries. This is why our two companies' partnership, Linde-SVW, is truly complementing and compatible," said Xu Zhengning, President of SVW. "This joint project is of great significance to SVW's VAM expansion project. The new joint venture will meet the demands of SVW's VAM plant on schedule and cost-effectively, to strive for best economic and social benefits." 

In the first phase of development under this Linde-SVW partnership, a new air separation plant with a capacity of 1,500 tonnes per day of oxygen will be constructed to produce and supply gases by 2011 to SVW's new 300,000 tons/year VAM plant. This air separation plant will be built and delivered by Linde's Engineering Division. In the long-term, the joint venture is intended to expand the capacities of air gases and also construct synthetic gas (HyCO) plants to meet the overall gases demand by SVW and its associated companies. 

SVW is 100% owned by China Petrochemical & Chemical Corporation (Sinopec) and has the largest natural gas-based chemical complex in China. SVW's existing products include vinyl acetate monomer (VAM), methanol (MeOH), polyvinyl alcohol (PVA) and ammonium. SVW's total investment for its VAM expansion project in CCIP is estimated to be EUR 580 million. SVW's VAM expansion project will include the construction of an acetylene plant unit, which employs a partial oxidation technology that requires oxygen. 

VAM is an essential chemical building block used in a wide variety of industrial and consumer products. VAM is a key ingredient in emulsion polymers, resins, and intermediates used in paints, adhesives, textiles, wire and cable polyethylene compounds, laminated safety glass, packaging, automotive plastic fuel tanks and acrylic fibers. 

The Linde Group is a world leading gases and engineering company with almost 52,000 employees working in around 100 countries worldwide. In the 2008 financial year it achieved sales of 12.7 billion euro. The strategy of The Linde Group is geared towards sustainable earnings-based growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. Linde is committed to technologies and products that unite the goals of customer value and sustainable development. 

In Greater China, Linde is headquartered in Shanghai and has around 50 wholly-owned companies and joint ventures, and more than 100 operational plants in major industrial hubs across the country, with around 2,500 employees. ´

For more information, see The Linde Group website at www.linde.com.


Further information:

Press
Uwe Wolfinger
Telephone: +49.89.35757-1320

Investor Relations
Thomas Eisenlohr
Telephone: +49.89.35757-1330
Media Contact
  • media@
    All Press Contacts
    •  
    • Sitemap
    • Terms of Use
    • Legal Notice
    • Data protection
  • © The Linde Group 2018